| abstract |
This article describes liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to immunogenic carriers. Also described are pharmaceutical compositions and uses for treating or preventing neurodegenerative diseases or conditions, such as liposomes and / or conjugates of Alzheimer's disease. |